Agios Pharmaceuticals | AGIO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 360.74B 23.94B 2026-04
Agios Pharmaceuticals USD 1.6B 410M 2026-04
Alnylam Pharmaceuticals USD 40.54B 12B 2026-04
Amgen USD 187.49B 11.24B 2026-04
Arrowhead Research USD 9.02B 4.25B 2025-12
Astellas Pharma JPY 4.13T 430.55B 2026-04
AstraZeneca USD 214.75B 86.5B 2026-04
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 28.34B 1.44B 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 122.54B 1.29B 2026-04
Daiichi Sankyo JPY 4.9T 1.44T 2026-04
Eli Lilly USD 882.91B 13.89B 2026-04
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 80.41B 3.39B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.9B 1.55B 2026-04
Merck USD 279.96B 18.7B 2026-04
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Novartis USD 231.75B 76B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12